Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Lundbeck Limited
Lundbeck House, Caldecotte Lake Business Park, Caldecotte, Milton Keynes, MK7 8LG
Telephone: +44 (0)1908 649 966
Fax: +44 (0)1908 647 888
WWW: http://www.lundbeck.co.uk
Medical Information Direct Line: +44 (0)1908 638 972
Medical Information e-mail: ukmedicalinformation@lundbeck.com
Customer Care direct line: +44 (0)1908 638 935

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 27/01/2012
PIL Cipramil Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 27/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
  • Change to dosage and administration
Updated on 06/04/2011 and displayed until 27/01/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
Updated on 12/07/2010 and displayed until 06/04/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 06/11/2009 and displayed until 12/07/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 25/09/2009 and displayed until 06/11/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change due to user-testing of patient information
Updated on 02/12/2008 and displayed until 25/09/2009
Reasons for adding or updating:
  • Change of contra-indications
  • Change to drug interactions
Updated on 17/04/2008 and displayed until 02/12/2008
Reasons for adding or updating:
  • Change to Further Information section
Updated on 26/03/2008 and displayed until 17/04/2008
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 30/08/2007 and displayed until 26/03/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to date of revision
Updated on 22/09/2006 and displayed until 30/08/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 12/05/2003 and displayed until 22/09/2006
Reasons for adding or updating:
  • Update to PIL
Updated on 16/08/2001 and displayed until 12/05/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 13/07/2001 and displayed until 16/08/2001
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
  citalopram hydrobromide